000 | 01327 a2200397 4500 | ||
---|---|---|---|
005 | 20250512014404.0 | ||
264 | 0 | _c19890614 | |
008 | 198906s 0 0 eng d | ||
022 | _a0004-4172 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOhhara, H | |
245 | 0 | 0 |
_aCardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. _h[electronic resource] |
260 |
_bArzneimittel-Forschung _cJan 1989 |
||
300 |
_a38-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnesthesia |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aPyridones _xpharmacology |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aOgawa, T | |
700 | 1 | _aTakeda, M | |
700 | 1 | _aKatoh, H | |
700 | 1 | _aDaiku, Y | |
700 | 1 | _aIgarashi, T | |
773 | 0 |
_tArzneimittel-Forschung _gvol. 39 _gno. 1 _gp. 38-45 |
|
999 |
_c2725620 _d2725620 |